The Lanier Law Firm is actively investigating evidence that Elmiron, a drug widely prescribed for a chronic bladder condition, appears to be toxic to the retina and can lead to permanent vision loss. Elmiron, manufactured by Janssen Pharmaceuticals, is a prescription medication used to treat bladder pain or pressure associated with interstitial cystitis, a condition that may also cause urinary urgency and frequency. Estimates show that hundreds of thousands of patients, primarily women, have been prescribed Elmiron since the mid 1990s.

Now, clinical studies reviewed by the American Academy of Ophthalmology have found that about 25 percent of patients with significant exposure to Elmiron showed definite signs of eye damage. Since the problems could mimic other known retinal conditions, such as age-related macular degeneration or pattern dystrophy, the percentage of patients suffering a toxic response to Elmiron could be even higher.

The Lanier Law Firm has a well-regarded record of success in holding drug companies accountable when they fail to warn doctors and patients of serious side effects from medications.  In this case, it appears that Janssen has never publicly acknowledged any vision-related issues with the use of the drug or even advised users to have regular eye exams. Our litigation team is prepared to pursue these claims on behalf of victims and hold the company accountable for these debilitating side effects.